This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cancer Neoantigen Vaccines

BOOKING CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
February 2, 2023 | 1-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET

Event Highlights

Why Attend?


Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still unclear when a cancer vaccine will be made commercially available; what is the latest academic research showing us? What is the industry missing and where are we going?

Join us through a series of inspiring keynote presentations and engaging panel discussions to connect with top pioneers in the space, to discuss the future of cancer immunotherapy and how neoantigens are transforming the field.